Nano-Armor Empowers Mesenchymal Stem Cells to Actively Target and Reverse Synovial Inflammation in Rheumatoid Arthritis.
Mesenchymal stem cell (MSC) therapy for rheumatoid arthritis (RA) remains hindered by the oxidative-induced pro-inflammatory synovial microenvironment, which largely impairs MSC homing, survival, and immunomodulatory function. Although nanomaterial modification holds promise for enhancing MSC therapeutic efficacy, conv...